Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway

Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway

BackgroundHyperbaric oxygen therapy (HBOT) has been confirmed as an effective and economical therapeutic modality for treating hemorrhagic cystitis (HC), whether induced by infection or acute graft-versus-host disease (aGVHD), in transplant recipients. However, its potential benefits in treating aGV...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Chao Xue, Hao Chen, Yiou Zhao, Dai Yuan, Xiaosheng Fang, Mei Ding, Huiting Qu, Xin Wang, Xueling Ge, Kang Lu, Yujie Jiang
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2025-02-01
Seri Bilgileri:Frontiers in Immunology
Konular:
allogeneic hematopoietic stem cell transplantation
acute graft-versus host disease
hyperbaric oxygen therapy
erythroid-derived 2-related factor 2 (Nrf2)
reactive oxygen species
Online Erişim:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1529176/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1529176/full

Benzer Materyaller